🔎 Trials Near Me

Beranda › Perdarahan Serebral › Texas

Uji klinis Perdarahan Serebral di Texas

6 studi untuk Perdarahan Serebral mencari peserta di lokasi di Texas.

Kota di Texas

Teks studi resmi (Bahasa Inggris)

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

  • University of Texas Medical Branch, Galveston
  • Houston Methodist Hospital, Houston
  • Memorial Hermann Texas Medical Center, Houston
  • dan 1 lainnya
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07260916

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

  • Houston Methodist Research Institute, Houston
  • UTHealth, Houston
  • University of Texas Health Science Center at San Antonio, San Antonio
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04916210

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

  • Memorial Hermann Memorial City Medical Center, Houston
  • Memorial Hermann-Texas Medical Center, Houston
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07227246

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • UT Southwestern Medical Center, Dallas
  • University of Texas Health Science Center San Antonio, San Antonio
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06402968

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  • Houston Methodist Hospital, Houston
  • Memorial Hermann Texas Medical Center, Houston
  • University of Texas Health Science Center San Antonio, San Antonio
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT03907046

Effect of the Stellate Ganglion Block on the Retinal Microcirculation

  • UT Southwestern Medical Center, Dallas
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Nov 2025 · NCT06797752

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.